PharmaLive: Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax

Links shared publicly online about this topic.

  • 533
    total visits

PharmaLive: Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax

pharmalive.com

PharmaLive: Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax

View full resource at pharmalive.com

Tags: Herpes Medication, Pharma, Zovirax

  • Share

Most Recently Shared on February 3, 2011 at 9:09 pm By:

pharmalive PharmaLive

Daily Advantage - Valeant Buys Zovirax From Glaxo for $300 Million - http://tinyurl.com/4qbdoag

1 year ago...

Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax - Drugs.com MedNews

drugs.com — “Valeant Pharmaceuticals International, Inc. (NYSE VRX) (TSX VRX) today announced that its subsidiary, Biovail Laboratories International SRL ( BLS ), has signedView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on February 3, 2011 at 6:06 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax: MISSISSAUGA, Ontario, Feb. 3, 2011... http://bit.ly/g3MNfY #drug

1 year ago...

Advertisement